• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极低热量生酮饮食对肥胖患者肠屏障完整性和功能的影响:一项初步研究。

The Effects of a Very-Low-Calorie Ketogenic Diet on the Intestinal Barrier Integrity and Function in Patients with Obesity: A Pilot Study.

机构信息

Functional Gastrointestinal Disorders Research Group, National Institute of Gastroenterology IRCCS "S. de Bellis", 70013 Castellana Grotte, Italy.

Center of Nutrition for the Research and the Care of Obesity and Metabolic Diseases, National Institute of Gastroenterology IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.

出版信息

Nutrients. 2023 May 30;15(11):2561. doi: 10.3390/nu15112561.

DOI:10.3390/nu15112561
PMID:37299524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10255565/
Abstract

The very-low-calorie ketogenic diet (VLCKD) is effective and safe for obese individuals, but limited information exists on its impact on the intestinal barrier. This study analyzed the effects of 8 weeks of VLCKD on 24 obese patients (11M/13F). Carbohydrate intake was fixed at 20-50 g/day, while protein and lipid intake varied from 1-1.4 g/kg of ideal body weight and 15-30 g per day, respectively. Daily calorie intake was below 800 kcal. The lactulose-mannitol absorption test assessed small intestinal permeability. Multiple markers, such as serum and fecal zonulin, fatty acid-binding protein, diamine oxidase concentrations, urinary dysbiosis markers (indican and skatole), and circulating lipopolysaccharide levels, were analyzed. Inflammation markers (serum interleukin 6, 8, 10, and tumor necrosis factor-α concentrations) were also evaluated. The results showed significant reductions in weight, BMI, and waist circumference post-diet. However, the lactulose-mannitol ratio increased by 76.5%, and a significant increase in dysbiosis markers at the end of the diet occurred. This trend was particularly evident in a subgroup of patients. Despite initial benefits, the VLCKD might negatively affect the intestinal barrier function in obese patients, potentially worsening their compromised intestinal balance.

摘要

极低卡路里生酮饮食(VLCKD)对肥胖个体有效且安全,但关于其对肠道屏障的影响的信息有限。本研究分析了 8 周 VLCKD 对 24 名肥胖患者(11M/13F)的影响。碳水化合物摄入量固定在 20-50 克/天,而蛋白质和脂肪摄入量分别为 1-1.4 克/公斤理想体重和每天 15-30 克。每日热量摄入低于 800 卡路里。乳果糖-甘露醇吸收试验评估了小肠通透性。分析了多种标志物,如血清和粪便肠通透素、脂肪酸结合蛋白、二胺氧化酶浓度、尿微生态失调标志物(吲哚和粪臭素)和循环脂多糖水平。还评估了炎症标志物(血清白细胞介素 6、8、10 和肿瘤坏死因子-α浓度)。结果表明,饮食后体重、BMI 和腰围显著减轻。然而,乳果糖-甘露醇比值增加了 76.5%,饮食结束时微生态失调标志物显著增加。这种趋势在患者亚组中尤为明显。尽管最初有获益,但 VLCKD 可能会对肥胖患者的肠道屏障功能产生负面影响,可能会使他们受损的肠道平衡恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/d72c342d6989/nutrients-15-02561-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/94dd80888900/nutrients-15-02561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/ce224a8a568f/nutrients-15-02561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/494e13edb240/nutrients-15-02561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/431dcffe690e/nutrients-15-02561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/3817d5a5574d/nutrients-15-02561-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/d72c342d6989/nutrients-15-02561-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/94dd80888900/nutrients-15-02561-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/ce224a8a568f/nutrients-15-02561-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/494e13edb240/nutrients-15-02561-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/431dcffe690e/nutrients-15-02561-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/3817d5a5574d/nutrients-15-02561-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f352/10255565/d72c342d6989/nutrients-15-02561-g006.jpg

相似文献

1
The Effects of a Very-Low-Calorie Ketogenic Diet on the Intestinal Barrier Integrity and Function in Patients with Obesity: A Pilot Study.极低热量生酮饮食对肥胖患者肠屏障完整性和功能的影响:一项初步研究。
Nutrients. 2023 May 30;15(11):2561. doi: 10.3390/nu15112561.
2
Metabolomic Profiling of Obese Patients with Altered Intestinal Permeability Undergoing a Very Low-Calorie Ketogenic Diet.肥胖患者肠道通透性改变行极低热量生酮饮食的代谢组学分析。
Nutrients. 2023 Dec 7;15(24):5026. doi: 10.3390/nu15245026.
3
Effects of a Very-Low-Calorie Ketogenic Diet on the Fecal and Urinary Volatilome in an Obese Patient Cohort: A Preliminary Investigation.极低卡路里生酮饮食对肥胖患者粪便和尿液挥发性代谢组的影响:一项初步研究。
Nutrients. 2023 Aug 28;15(17):3752. doi: 10.3390/nu15173752.
4
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study.极低卡路里生酮饮食(VLCKD)在治疗化脓性汗腺炎(反向痤疮)中的应用:改善疾病临床严重程度的有效且安全的工具。一项初步研究的结果。
J Transl Med. 2024 Feb 13;22(1):149. doi: 10.1186/s12967-024-04853-0.
5
Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting.通过多相极低卡路里生酮饮食方案降低超重/肥胖女性的心血管代谢风险和体重:真实环境中的研究。
Nutrients. 2021 May 26;13(6):1804. doi: 10.3390/nu13061804.
6
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis.极低卡路里生酮饮食(VLCKD)在超重和肥胖患者中的疗效和安全性:系统评价和荟萃分析。
Rev Endocr Metab Disord. 2020 Mar;21(1):5-16. doi: 10.1007/s11154-019-09514-y.
7
European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis.欧洲极低卡路里生酮饮食成人肥胖管理指南:系统评价和荟萃分析。
Obes Facts. 2021;14(2):222-245. doi: 10.1159/000515381. Epub 2021 Apr 21.
8
Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne?极低卡路里生酮饮食(VLCKD):治疗痤疮的营养工具?
J Transl Med. 2024 Mar 31;22(1):322. doi: 10.1186/s12967-024-05119-5.
9
Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.2 个月极低卡路里生酮饮食(VLCKD)与标准低卡路里饮食在减少肥胖患者内脏和肝脏脂肪积累方面的疗效比较。
Front Endocrinol (Lausanne). 2020 Sep 14;11:607. doi: 10.3389/fendo.2020.00607. eCollection 2020.
10
The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.极低卡路里生酮饮食对肥胖人群肠道微生物组成的影响。
Nutrients. 2023 Jun 13;15(12):2728. doi: 10.3390/nu15122728.

引用本文的文献

1
Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept study.生酮饮食改善银屑病关节炎的疾病活动度和心血管风险:一项概念验证研究。
PLoS One. 2025 Apr 22;20(4):e0321140. doi: 10.1371/journal.pone.0321140. eCollection 2025.
2
Advancing Obesity Management: the Very Low-Energy Ketogenic therapy (VLEKT) as an Evolution of the "Traditional" Ketogenic Diet.推进肥胖管理:极低能量生酮疗法(VLEKT)作为“传统”生酮饮食的演变
Curr Obes Rep. 2025 Apr 3;14(1):30. doi: 10.1007/s13679-025-00622-2.
3
Effects of the Ketogenic Diet on Microbiota Composition and Short-Chain Fatty Acids in Women with Overweight/Obesity.

本文引用的文献

1
High-fat diet induces intestinal mucosal barrier dysfunction in ulcerative colitis: emerging mechanisms and dietary intervention perspective.高脂饮食诱发溃疡性结肠炎肠道黏膜屏障功能障碍:新机制及饮食干预视角
Am J Transl Res. 2023 Feb 15;15(2):653-677. eCollection 2023.
2
The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.八周极低卡路里生酮饮食(VLCKD)对超重和肥胖人群肝脏健康的影响。
Nutrients. 2023 Feb 6;15(4):825. doi: 10.3390/nu15040825.
3
Is intestinal permeability increased in obesity? A review including the effects of dietary, pharmacological and surgical interventions on permeability and the microbiome.
生酮饮食对超重/肥胖女性微生物群组成和短链脂肪酸的影响。
Nutrients. 2024 Dec 19;16(24):4374. doi: 10.3390/nu16244374.
4
Serum zonulin and colorectal cancer risk.血清肠通透素与结直肠癌风险。
Sci Rep. 2024 Nov 15;14(1):28171. doi: 10.1038/s41598-024-76697-z.
5
Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence.酮症干预治疗常染色体显性遗传多囊肾病:当前证据的综合评价。
Nutrients. 2024 Aug 13;16(16):2676. doi: 10.3390/nu16162676.
6
Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice.临床生酮饮食中的膳食纤维含量会改变小鼠的肠道微生物群并增强其抗癫痫能力。
bioRxiv. 2024 Jul 31:2024.07.31.606041. doi: 10.1101/2024.07.31.606041.
7
Extracellular Vesicles Modulate Liver Cells Viability and Reactive Oxygen Species in Patients Following a Very Low-Calorie Ketogenic Diet.细胞外囊泡调节极低热量生酮饮食后患者的肝实质细胞活力和活性氧。
Nutrients. 2024 Jul 23;16(15):2386. doi: 10.3390/nu16152386.
8
A Multi-Omics Approach to Disclose Metabolic Pathways Impacting Intestinal Permeability in Obese Patients Undergoing Very Low Calorie Ketogenic Diet.采用多组学方法揭示极低热量生酮饮食对肥胖患者肠通透性的影响的代谢途径。
Nutrients. 2024 Jun 28;16(13):2079. doi: 10.3390/nu16132079.
9
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.超重和肥胖代谢功能障碍相关脂肪性肝病患者极低卡路里生酮饮食 8 周前后肝脂肪变性和纤维化的性别差异。
Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408.
10
Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity.超重和肥胖患者接受极低卡路里生酮饮食(VLCKD)八周后,高水平脂肪变性与代谢功能障碍相关脂肪性肝病的改善程度更大。
Nutrients. 2024 Mar 18;16(6):874. doi: 10.3390/nu16060874.
肥胖会导致肠道通透性增加吗?一项综述,涵盖饮食、药物和手术干预对通透性及微生物群的影响
Diabetes Obes Metab. 2023 Feb;25(2):325-330. doi: 10.1111/dom.14899. Epub 2022 Nov 2.
4
Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence.极低卡路里生酮饮食能否消除肥胖中的低度炎症?新出现的证据。
Crit Rev Food Sci Nutr. 2023;63(26):8320-8336. doi: 10.1080/10408398.2022.2054935. Epub 2022 Apr 4.
5
The association of weight loss with changes in the gut microbiota diversity, composition, and intestinal permeability: a systematic review and meta-analysis.体重减轻与肠道微生物多样性、组成和肠道通透性变化的关联:系统评价和荟萃分析。
Gut Microbes. 2022 Jan-Dec;14(1):2020068. doi: 10.1080/19490976.2021.2020068.
6
VLCKD: a real time safety study in obesity.VLCKD:肥胖患者的实时安全性研究。
J Transl Med. 2022 Jan 8;20(1):23. doi: 10.1186/s12967-021-03221-6.
7
Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice.生酮饮食会加重葡聚糖硫酸钠(DSS)诱导的小鼠结肠炎,损害肠道屏障,并改变肠道微生物群和代谢。
Food Funct. 2021 Oct 19;12(20):10210-10225. doi: 10.1039/d1fo02288a.
8
The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition.极低热量、极低热量生酮饮食和极低碳水化合物饮食对肠道微生物组成的潜在作用。
Front Endocrinol (Lausanne). 2021 May 14;12:662591. doi: 10.3389/fendo.2021.662591. eCollection 2021.
9
Intestinal barrier function in obesity with or without metabolic syndrome: a systematic review protocol.肥胖伴或不伴代谢综合征患者肠屏障功能:系统评价方案。
BMJ Open. 2021 May 21;11(5):e043959. doi: 10.1136/bmjopen-2020-043959.
10
Biomarkers for assessment of intestinal permeability in clinical practice.用于临床评估肠通透性的生物标志物。
Am J Physiol Gastrointest Liver Physiol. 2021 Jul 1;321(1):G11-G17. doi: 10.1152/ajpgi.00113.2021. Epub 2021 May 19.